Skye Bioscience SKYE
NASDAQ SKYE
$1.68 +0.08 (+5.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Skye Bioscience (SKYE) Selling, General & Administrative (2012 - 2026)

Updated

Skye Bioscience (SKYE) reported Selling, General & Administrative of $3.87 million for Q2 2026, down 0.9% from $3.91 million a year earlier and down 18.3% from the prior quarter.

Analysis

Skye Bioscience (SKYE) Selling, General & Administrative (2012 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Skye Bioscience's Selling, General & Administrative came in at $15.94 million, down 9.7% year-over-year; for FY2025, it came in at $15.8 million, down 10.9% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of 29.5% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $17.73 million in FY2024 (+125.7%), $7.85 million in FY2023 (+28.8%), $6.09 million in FY2022 (+24.0%) and $4.92 million in FY2021 (+13.2%).
  • Five-year quarterly Selling, General & Administrative spans a low of $1.14 million in Q3 2022 and a high of $4.74 million in Q1 2026.
  • Year over year, Selling, General & Administrative gained in four of the last eight quarters, with growth averaging 18.9%.
  • The high point for year-over-year Selling, General & Administrative in five years was Q2 2024 (growth of 258.7%); the low point was Q2 2023 (a decline of 32.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $4.74 million (Q1 2026), $3.43 million (Q4 2025) and $3.91 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Skye Bioscience 7.03 Mn 7.03 Mn - 3.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.87 Mn
Mar 31, 2026 4.74 Mn
Dec 31, 2025 3.43 Mn
Sep 30, 2025 3.91 Mn
Jun 30, 2025 3.91 Mn
Mar 31, 2025 4.56 Mn
Dec 31, 2024 4.55 Mn
Sep 30, 2024 4.64 Mn
Jun 30, 2024 4.33 Mn
Mar 31, 2024 4.21 Mn
Dec 31, 2023 2.49 Mn
Sep 30, 2023 2.24 Mn
Jun 30, 2023 1.21 Mn
Mar 31, 2023 1.92 Mn
Dec 31, 2022 1.54 Mn
Sep 30, 2022 1.14 Mn
Jun 30, 2022 1.79 Mn
Mar 31, 2022 1.62 Mn
Dec 31, 2021 1.35 Mn
Sep 30, 2021 1.49 Mn
API Access

Skye Bioscience Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SKYE&period=max&api_key=YOUR_API_KEY